At Axleres Biosciences, we understand that no two drug development journeys are the same — and neither are the obstacles. Whether you're navigating complex modalities, coordinating across fragmented teams, or trying to rescue a timeline that’s slipping, our business models are designed to meet you where you are and move your program forward with clarity, speed, and scientific rigor.
We offer two flexible pathways to suit your organizational preferences and operational frameworks — both grounded in collaboration, trust, and technical excellence.
In this model, you retain your direct commercial relationship with the CRDMO or partner organization, while Axleres acts as your integrated program management and scientific oversight team. We stay deeply embedded in your project — aligning stakeholders, troubleshooting cross-functional issues, resolving bottlenecks, and ensuring your external teams deliver on time, with quality and transparency.
In this model, Axleres becomes your single point of responsibility. We contract directly with you and coordinate all downstream execution through our pre-qualified and curated network of CRDMOs and subject matter experts — ensuring quality, cost-efficiency, and speed at every step. You benefit from our strong partner relationships, scientific due diligence, and ability to pivot quickly, if needed.
No matter what model you choose, our role remains the same: to help you regain control, restore momentum, and move your program forward — faster and smarter.
Let’s design the model that works best for your goals, your team, and your therapeutic promise.